Nanotechnology Now

Our NanoNews Digest Sponsors





Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > Techulon Expands Coverage in Northern Virginia/Maryland Biotech Corridor: Local Sales and Technical Support for Glycofect™ Reagents to Government and University Laboratories

Abstract:
Techulon Inc., the leader in low-toxicity gene delivery has announced a series of expansions to provide enhanced customer support and direct access to the Company's innovative Glycofect transfection reagent in the Northern Virginia/Maryland Technology Corridor. The Company is dedicated to providing compelling technology for the most challenging DNA delivery needs in key research regions where demand for Glycofect and knowledgeable support are required.

Techulon Expands Coverage in Northern Virginia/Maryland Biotech Corridor: Local Sales and Technical Support for Glycofect™ Reagents to Government and University Laboratories

Blacksburg, VA | Posted on October 6th, 2011

Techulon is pleased Mr. Bill McKay of Olney Biosciences has joined our efforts to provide key account professional services in the Mid-Atlantic region. Mr. McKay will coordinate activities and directly serve clients such as the National Institutes of Health, the National Cancer Institute, and John Hopkins University. "Serving the critical research of NIH and related firms across this biotech community is a privilege and I'm pleased to be working with Techulon to deliver such a quality product," said Bill McKay.

Providing educational information about the Glycofect platform will be the central focus driving Techulon events through the next several months. Techulon is establishing a regular series of seminars and events to provide guidance and training for cell researchers as they begin expanded use of Glycofect in highly critical research programs including Glioma and cortical neurons, dermal fibroblasts and aortic smooth muscle cells. Techulon will roll out its educational initiatives as a focal participant at the October NIH Research Festival at the Institute's main Bethesda campus, and continue to present frequent luncheon workshops throughout 2012. Research team leaders interested in hosting an event should contact Mr. McKay at

"We are gratified that Glycofect is enabling and accelerating research on critical primary cell types and we want to show our commitment to our growing customer base in this important region. Customer awareness and support are top priorities for us as we see the increased use of Glycofect among the research community," said Frank Akers, President of Techulon.

Glycofect is a polymeric nanoparticle-delivery transfection reagent designed to be particularly effective in primary cells of therapeutic interest. It is being used in over 20 countries by government, university and corporate laboratories for advanced research towards better understanding of cell biology and for development of new cell-based therapeutics.

####

About Techulon Inc.
Techulon, Inc. is a life sciences company headquartered in Blacksburg, VA, with a core capability in novel biodegradable and low toxicity DNA and RNA delivery reagents for cell-based research and therapeutics.

For more information, please click here

Contacts:
Techulon
Frank Akers, President
540-443-9254

Copyright © Business Wire

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Iran to Hold 3rd Int'l Engineering Materials, Metallurgy Conference October 25th, 2014

Haydale Secures Exclusive Development and Supply Agreement with Tantec A/S: New reactors to be built and commissioned by Tantec A/S represent another step forward towards the commercialisation of graphene October 24th, 2014

QuantumWise guides the semiconductor industry towards the atomic scale October 24th, 2014

SUNY Polytechnic Institute Invites the Public to Attend its Popular Statewide 'NANOvember' Series of Outreach and Educational Events October 23rd, 2014

Openings/New facilities/Groundbreaking/Expansion

HP Supercomputer at NREL Garners Top Honor October 19th, 2014

Graphenea opens US branch October 16th, 2014

Raytheon, UMass Lowell open on-campus research institute: Industry leader’s researchers to collaborate with faculty, students to move key technologies forward through first-of-its-kind partnership October 11th, 2014

Yale University and Leica Microsystems Partner to Establish Microscopy Center of Excellence: Yale Welcomes Scientists to Participate in Core Facility Opening and Super- Resolution Workshops October 20 Through 31, 2014 September 30th, 2014

Nanomedicine

NYU Researchers Break Nano Barrier to Engineer the First Protein Microfiber October 23rd, 2014

Iranian Scientists Apply Nanotechnology to Produce Surgery Suture October 23rd, 2014

RF Heating of Magnetic Nanoparticles Improves the Thawing of Cryopreserved Biomaterials October 23rd, 2014

Sopping up proteins with thermosponges: Researchers develop novel nanoparticle platform that proves effective in delivering protein-based drugs October 22nd, 2014

Announcements

Iran to Hold 3rd Int'l Engineering Materials, Metallurgy Conference October 25th, 2014

Haydale Secures Exclusive Development and Supply Agreement with Tantec A/S: New reactors to be built and commissioned by Tantec A/S represent another step forward towards the commercialisation of graphene October 24th, 2014

QuantumWise guides the semiconductor industry towards the atomic scale October 24th, 2014

Strengthening thin-film bonds with ultrafast data collection October 23rd, 2014

NanoNews-Digest
The latest news from around the world, FREE





  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE